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Dear Editor, 25 
We thank Nguyen et al.1 for their interest in our recent publication in Osteoarthritis and Cartilage 26 
entitled “Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome 27 
from two parallel randomized controlled trials”2. 28 
We do agree with the authors that clarity and transp rency are crucial when reporting research 29 
findings. We believe our report from the two, parallel randomized controlled trials is adequate in 30 
terms of the comments given and aligns with best practice.  31 
First, in the title, abstract, main text and in thefigure legends, we clearly state that we are reporting 32 
the results from two parallel randomized controlled trials. Furthermore, both trial registration 33 
numbers are stated at the end of the abstract as required by Osteoarthritis and Cartilage and 34 
suggested by CONSORT. In the introduction and methods, we provide a thorough and transparent 35 
description of similarities and differences between the two trials. Based on our reporting, we find it 36 
difficult to believe that a reader would misinterpret this as a single four-arm trial. Second, to 37 
highlight that this is an extended follow-up of the two trials we refer to the primary reports3,4 in the 38 
introduction and the methods. As written by Nguyen et al,1 we clearly defined the primary outcome 39 
in this extended report as the between-group difference in change in Knee Injury and Osteoarthritis 40 
Outcome Score subscales, covering pain, symptoms, activities of daily living, and quality of life 41 
(KOOS4) at 24 months while the primary endpoint of the two trials was the mean between-group 42 
difference in change in the KOOS4 at 12 months.   43 
 44 
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